"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.

A surprising new study has uncovered over 200 misfolded proteins in the brains of aging rats with cognitive decline, beyond ...

Neuroscientists have taken a major step toward detecting Alzheimer’s disease in its earliest stages—long before memory loss ...

Understand the 6 stages of Alzheimer’s disease, from early signs to final care, and how families can support loved ones ...

For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...

Altering cellular interactions around amyloid plaques may offer novel Alzheimer's treatment strategies. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 05 ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, ...

The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond ...

Once again looking at how suppressing PDE4B might affect the brain, the UK team genetically modified mice with Alzheimer's and amyloid plaques in the brain to have reduced PDE4B activity.

Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, the drugs boost levels of a healthy form of amyloid beta (Aβ42 ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting brain protein amounts may offer cognitive benefits.